Literature DB >> 7995625

Additive effects of obesity, hypertension, and type 2 diabetes on insulin resistance.

P Maheux1, J Jeppesen, W H Sheu, C B Hollenbeck, C Clinkingbeard, M S Greenfield, Y D Chen, G M Reaven.   

Abstract

Resistance to insulin-mediated glucose disposal has been previously shown to be increased in association with obesity, high blood pressure, and non-insulin-dependent diabetes mellitus. We initiated the present study to quantify the separate effects of hypertension and non-insulin-dependent diabetes mellitus on insulin resistance in both nonobese and obese subjects. To accomplish this, 88 subjects were divided into the following five experimental groups: normal blood pressure, nonobese (n = 17); normal blood pressure, obese (n = 18); high blood pressure, nonobese (n = 18); high blood pressure, obese (n = 19); and high blood pressure, obese, non-insulin-dependent diabetes mellitus (n = 16). Plasma glucose and insulin concentrations were measured before and after a 75-g oral glucose load. Resistance to insulin-mediated glucose disposal was estimated by determining the steady-state plasma insulin and glucose concentrations during the last 30 minutes of a continuous infusion of somatostatin (5 micrograms/min), exogenous insulin (25 mU/m2 per minute), and glucose (240 mg/m2 per minute). Since the steady-state plasma insulin concentrations are similar in all subjects, the higher the steady-state plasma glucose, the more insulin resistant the individual. Nonobese subjects with normal blood pressure had the lowest plasma glucose and insulin responses and steady-state plasma glucose concentrations, and their values were significantly different from the other four groups. Obese or nonobese subjects with high blood pressure had significantly higher plasma glucose responses and steady-state plasma glucose concentrations than did their respective weight-matched control subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7995625     DOI: 10.1161/01.hyp.24.6.695

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

1.  Evolution of insulin resistance in coronary artery disease patients on four different pharmacological therapies.

Authors:  G Piédrola; E Novo; J Serrano-Gotarredona; M L de Teresa; R García-Robles
Journal:  Postgrad Med J       Date:  1999-01       Impact factor: 2.401

Review 2.  Sphingolipids in obesity, type 2 diabetes, and metabolic disease.

Authors:  S B Russo; J S Ross; L A Cowart
Journal:  Handb Exp Pharmacol       Date:  2013

3.  Consistency of the disposition index in the face of diet induced insulin resistance: potential role of FFA.

Authors:  Darko Stefanovski; Joyce M Richey; Orison Woolcott; Maya Lottati; Dan Zheng; Lisa N Harrison; Viorica Ionut; Stella P Kim; Isabel Hsu; Richard N Bergman
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

4.  Prevalence of poor glycemic and blood pressure control and pattern of drug use among primary health-care outpatients in Al Ahsa Saudi Arabia.

Authors:  Promise M Emeka; Ahmed Al Mukalaf; Hussien Al Helal; Tahir M Khan; Mishial A Almukalf
Journal:  Int J Health Sci (Qassim)       Date:  2017 Jul-Sep

5.  A novel use of structural equation models to examine factors associated with prediabetes among adults aged 50 years and older: National Health and Nutrition Examination Survey 2001-2006.

Authors:  Barbara H Bardenheier; Kai McKeever Bullard; Carl J Caspersen; Yiling J Cheng; Edward W Gregg; Linda S Geiss
Journal:  Diabetes Care       Date:  2013-05-06       Impact factor: 19.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.